Leprecan

Leprecan is a protein associated with osteogenesis imperfecta^[1] type VIII.

Leprecan is part of a superfamily of 2OG-Fe(II) dioxygenase, along with DNA repair protein AlkB, and disease resistant EGL-9. The enzyme was found to be a type of hydroxylases used in the substrate formation of protein glysosylation.^[2]

References

↑ Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, et al. (March 2007). “Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta”. Nature Genetics. 39 (3): 359–65. doi:10.1038/ng1968. PMID 17277775.
↑ Aravind L, Koonin EV (2001-02-19). “The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases”. Genome Biology. 2 (3): RESEARCH0007. doi:10.1186/gb-2001-2-3-research0007. PMID 11276424.

External links

leprecan+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)

[pmid18566967-1] Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, et al. (March 2007). “Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta”. Nature Genetics. 39 (3): 359–65. doi:10.1038/ng1968. PMID 17277775.

[2] Aravind L, Koonin EV (2001-02-19). “The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases”. Genome Biology. 2 (3): RESEARCH0007. doi:10.1186/gb-2001-2-3-research0007. PMID 11276424.

[1]

[2]

Leprecan

References

External links

Looking for the patient version?